Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BioLineRx gets second HCV candidate from GenoScience; this one co-discovered by RFS Pharma

Executive Summary

Antiviral therapeutics developer GenoScience Pharma and RFS Pharma LLC (developing treatments for HIV, hepatitis, and cancer) have licensed Israeli specialty pharma BioLineRx Ltd. exclusive global rights to a preclinical oral hepatitis C candidate, which BioLineRx has named BL8030.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies